154 related articles for article (PubMed ID: 31387748)
1. TRPV4 expresses in bone cell lineages and TRPV4-R616Q mutant causing Brachyolmia in human reveals "loss-of-interaction" with cholesterol.
Das R; Goswami C
Biochem Biophys Res Commun; 2019 Oct; 517(4):566-574. PubMed ID: 31387748
[TBL] [Abstract][Full Text] [Related]
2. Influence of membrane cholesterol in the molecular evolution and functional regulation of TRPV4.
Kumari S; Kumar A; Sardar P; Yadav M; Majhi RK; Kumar A; Goswami C
Biochem Biophys Res Commun; 2015 Jan; 456(1):312-9. PubMed ID: 25434996
[TBL] [Abstract][Full Text] [Related]
3. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass.
Masuyama R; Mizuno A; Komori H; Kajiya H; Uekawa A; Kitaura H; Okabe K; Ohyama K; Komori T
J Bone Miner Res; 2012 Aug; 27(8):1708-21. PubMed ID: 22492541
[TBL] [Abstract][Full Text] [Related]
4. Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation.
Kang SS; Shin SH; Auh CK; Chun J
Exp Mol Med; 2012 Dec; 44(12):707-22. PubMed ID: 23143559
[TBL] [Abstract][Full Text] [Related]
5. Progesterone interacts with the mutational hot-spot of TRPV4 and acts as a ligand relevant for fast Ca
Dubey NK; Mishra S; Goswami C
Biochim Biophys Acta Biomembr; 2023 Aug; 1865(6):184178. PubMed ID: 37225030
[TBL] [Abstract][Full Text] [Related]
6. L596-W733 bond between the start of the S4-S5 linker and the TRP box stabilizes the closed state of TRPV4 channel.
Teng J; Loukin SH; Anishkin A; Kung C
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3386-91. PubMed ID: 25737550
[TBL] [Abstract][Full Text] [Related]
7. Wild-type and brachyolmia-causing mutant TRPV4 channels respond directly to stretch force.
Loukin S; Zhou X; Su Z; Saimi Y; Kung C
J Biol Chem; 2010 Aug; 285(35):27176-27181. PubMed ID: 20605796
[TBL] [Abstract][Full Text] [Related]
8. Human skeletal dysplasia causing L596P-mutant alters the conserved amino acid pattern at the lipid-water-Interface of TRPV4.
Das R; Mohanta S; Dubey NK; Das NK; Goswami C
Biochim Biophys Acta Biomembr; 2023 Feb; 1865(2):184085. PubMed ID: 36403799
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome C interacts with the pathogenic mutational hotspot region of TRPV4 and forms complexes that differ in mutation and metal ion-sensitive manner.
Das R; Kumar A; Dalai R; Goswami C
Biochem Biophys Res Commun; 2022 Jun; 611():172-178. PubMed ID: 35490656
[TBL] [Abstract][Full Text] [Related]
10. Role of TRPV4 in skeletal function and its mutant-mediated skeletal disorders.
Das R; Goswami C
Curr Top Membr; 2022; 89():221-246. PubMed ID: 36210150
[TBL] [Abstract][Full Text] [Related]
11. A mutation in TRPV4 results in altered chondrocyte calcium signaling in severe metatropic dysplasia.
Hurd L; Kirwin SM; Boggs M; Mackenzie WG; Bober MB; Funanage VL; Duncan RL
Am J Med Genet A; 2015 Oct; 167A(10):2286-93. PubMed ID: 26249260
[TBL] [Abstract][Full Text] [Related]
12. TRPV4-dependent Ca
Kuwashima Y; Yanagawa M; Maekawa M; Abe M; Sako Y; Arita M
Biophys J; 2024 Apr; 123(7):867-884. PubMed ID: 38433447
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant brachyolmia in a large Swedish family: phenotypic spectrum and natural course.
Grigelioniene G; Geiberger S; Horemuzova E; Moström E; Jäntti N; Neumeyer L; Åström E; Nordenskjöld M; Nordgren A; Mäkitie O
Am J Med Genet A; 2014 Jul; 164A(7):1635-41. PubMed ID: 24677493
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
Rock MJ; Prenen J; Funari VA; Funari TL; Merriman B; Nelson SF; Lachman RS; Wilcox WR; Reyno S; Quadrelli R; Vaglio A; Owsianik G; Janssens A; Voets T; Ikegawa S; Nagai T; Rimoin DL; Nilius B; Cohn DH
Nat Genet; 2008 Aug; 40(8):999-1003. PubMed ID: 18587396
[TBL] [Abstract][Full Text] [Related]
15. Human mutations highlight an intersubunit cation-π bond that stabilizes the closed but not open or inactivated states of TRPV channels.
Teng J; Anishkin A; Kung C; Blount P
Proc Natl Acad Sci U S A; 2019 May; 116(19):9410-9416. PubMed ID: 31010928
[TBL] [Abstract][Full Text] [Related]
16. Accelerated osteoblastic differentiation in patient-derived dental pulp stem cells carrying a gain-of-function mutation of TRPV4 associated with metatropic dysplasia.
Han X; Kato H; Sato H; Hirofuji Y; Fukumoto S; Masuda K
Biochem Biophys Res Commun; 2020 Mar; 523(4):841-846. PubMed ID: 31954514
[TBL] [Abstract][Full Text] [Related]
17. Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension.
Lakk M; Hoffmann GF; Gorusupudi A; Enyong E; Lin A; Bernstein PS; Toft-Bertelsen T; MacAulay N; Elliott MH; Križaj D
J Lipid Res; 2021; 62():100145. PubMed ID: 34710431
[TBL] [Abstract][Full Text] [Related]
18. A channelopathy mechanism revealed by direct calmodulin activation of TrpV4.
Loukin SH; Teng J; Kung C
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9400-5. PubMed ID: 26170305
[TBL] [Abstract][Full Text] [Related]
19. Protein informatics combined with multiple data sources enriches the clinical characterization of novel TRPV4 variant causing an intermediate skeletal dysplasia.
Hines SL; Richter JE; Mohammad AN; Mahim J; Atwal PS; Caulfield TR
Mol Genet Genomic Med; 2019 Mar; 7(3):e566. PubMed ID: 30693671
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal domain of TRPV4 channel is involved in its trafficking to the nucleus.
Méndez-Gómez S; Espadas-Álvarez H; Ramírez-Rodríguez I; Domínguez-Malfavón L; García-Villegas R
Biochem Biophys Res Commun; 2022 Feb; 592():13-17. PubMed ID: 35007845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
